| 5-HIAA | 5-hydroxyindoleacetic acid |
| 5-HT | 5-hydroxytryptamine (serotonin) |
| AGEs | Advanced glycation end products |
| ALA | Alanine |
| ANOVA | Analysis of variance |
| ASP | Aspartic acid |
| b.w. | Body weight |
| Con | Healthy control group |
| CNS | Central nervous system |
| DA | Dopamine |
| DOPAC | 3,4-dihydroxyphenylacetic acid |
| EAAT1, GLAST | Astrocytic glutamate transporters 1 |
| EAAT2, GLT-1 | Astrocytic glutamate transporter 2 |
| FF | Foot Fault test |
| GABA | γ-aminobutyric acid |
| GH | Post-hoc Games–Howell test |
| GLU | Glutamate |
| HB | Hole–Board test |
| HIS | Histidine |
| HPLC-ED | High-performance liquid chromatography with electrochemical detection |
| HVA | Homovanillic acid |
| LRR | Loss of righting reflex |
| MHPG | 3-methoxy-4-hydroxyphenylglycol |
| MWM | Morris Water Maze test |
| NA | Noradrenaline |
| NK | Post-hoc Newman–Keuls test |
| NOR | Novel Object Recognition test |
| OF | Open Field test |
| PCA | Protocatechuic acid |
| PCA50 | PCA administered at dose 50 mg/kg b.w. |
| PCA100 | PCA administered at dose 100 mg/kg b.w. |
| PTD | Pyrithiamine-induced thiamine deficiency |
| SER | Serine |
| TAU | Taurine |
| TD | Thiamine deficiency |
| THR | Threonine |
| WKS | Wernicke–Korsakoff syndrome |